Syntara Ltd (ASX:SNT) Secures A$15 Million Placement
Syntara Ltd raises A$15 million through a share placement to fund its clinical trials and strengthen its financial position.
Category: Healthcare
Syntara Limited (ASX:SNT) Announces $15 Million Equity Raising
Syntara Limited (ASX:SNT) announces a $15 million equity placement to fund its clinical trial programs, primarily focusing on SNT-5505.
Aldoro Resources Limited (ASX:ARN) Confirms Niobium Mineralisation
Aldoro Resources (ASX:ARN) confirms significant niobium mineralisation at Kameelburg, marking a strong continued exploration effort.
Immutep Limited (ASX:IMM) Reports Promising Clinical Data
Immutep Limited (ASX:IMM) reveals promising data for HNSCC from the TACTI-003 trial, suggesting an effective therapy for underserved patients.
Orthocell Limited (ASX:OCC) Achieves First Sales of Remplir™
Orthocell Limited reports first sales of Remplir™ in Singapore, ahead of schedule, highlighting a strong start for its commercialisation strategy.
Cynata Therapeutics Limited (ASX:CYP) Treats First Patient in Kidney Transplant Trial
Cynata Therapeutics (ASX:CYP) has successfully treated its first patient in a kidney transplant clinical trial with CYP-001.
Vinyl Group (ASX:VNL) to Acquire Concrete Playground
Vinyl Group (ASX:VNL) has announced their acquisition of Concrete Playground for $5 million, enhancing their EBITDA and accelerating cash flow.
Buxton Resources Ltd (ASX:BUX) Reports High-Grade Graphite Intersections
Buxton Resources Ltd reports significant high-grade graphite results at Graphite Bull, anticipating further resource growth.
LTR Pharma Limited (ASX:LTP) Launches Online Men’s Health Platform
LTR Pharma launches its online telehealth platform for men’s health, enabling access to SPONTAN treatment ahead of schedule.
BCAL Diagnostics Limited (ASX:BDX) Receives NATA Accreditation
BCAL Diagnostics Limited (ASX: BDX) receives NATA accreditation, advancing its BREASTEST® commercialisation efforts.